Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Mechanisms of foxp3+ T regulatory cell-mediated suppression.

Shevach EM.

Immunity. 2009 May;30(5):636-45. doi: 10.1016/j.immuni.2009.04.010. Review.

2.

Critical roles of Bim in T cell activation and T cell-mediated autoimmune inflammation in mice.

Ludwinski MW, Sun J, Hilliard B, Gong S, Xue F, Carmody RJ, DeVirgiliis J, Chen YH.

J Clin Invest. 2009 Jun;119(6):1706-13. doi: 10.1172/JCI37619.

3.

In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression.

Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, Surh CD, Grey ST, Sprent J.

J Exp Med. 2009 Apr 13;206(4):751-60. doi: 10.1084/jem.20082824. Epub 2009 Mar 30.

4.

Interleukin-2 in the development and control of inflammatory disease.

Hoyer KK, Dooms H, Barron L, Abbas AK.

Immunol Rev. 2008 Dec;226:19-28. doi: 10.1111/j.1600-065X.2008.00697.x. Review.

PMID:
19161413
5.

CTLA-4 control over Foxp3+ regulatory T cell function.

Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, Nomura T, Sakaguchi S.

Science. 2008 Oct 10;322(5899):271-5. doi: 10.1126/science.1160062.

6.

Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity.

Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT, Bluestone JA.

J Exp Med. 2008 Sep 1;205(9):1983-91. doi: 10.1084/jem.20080707. Epub 2008 Aug 25.

7.

Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.

Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR Jr, Muller W, Rudensky AY.

Immunity. 2008 Apr;28(4):546-58. doi: 10.1016/j.immuni.2008.02.017.

8.

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.

Tang Q, Bluestone JA.

Nat Immunol. 2008 Mar;9(3):239-44. doi: 10.1038/ni1572. Review.

9.

A two-step process for thymic regulatory T cell development.

Lio CW, Hsieh CS.

Immunity. 2008 Jan;28(1):100-11. doi: 10.1016/j.immuni.2007.11.021.

10.

The biology of interleukin-2.

Malek TR.

Annu Rev Immunol. 2008;26:453-79. Review.

PMID:
18062768
11.

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells.

Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ.

Nat Immunol. 2007 Dec;8(12):1353-62. Epub 2007 Nov 4.

PMID:
17982458
12.

Targeting T cell-specific costimulators and growth factors in a model of autoimmune hemolytic anemia.

Hoyer KK, Wolslegel K, Dooms H, Abbas AK.

J Immunol. 2007 Sep 1;179(5):2844-50.

13.

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.

Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC.

J Exp Med. 2007 Jun 11;204(6):1257-65. Epub 2007 May 14.

14.
15.

Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J.

Science. 2006 Mar 31;311(5769):1924-7. Epub 2006 Feb 16.

16.

A function for interleukin 2 in Foxp3-expressing regulatory T cells.

Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY.

Nat Immunol. 2005 Nov;6(11):1142-51. Epub 2005 Oct 16. Erratum in: Nat Immunol. 2006 Apr;7(4):427.

PMID:
16227984
17.
18.

Regulatory T cell lineage specification by the forkhead transcription factor foxp3.

Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY.

Immunity. 2005 Mar;22(3):329-41.

19.

The role of BH3-only proteins in the immune system.

Strasser A.

Nat Rev Immunol. 2005 Mar;5(3):189-200. Review.

PMID:
15719025
20.

Supplemental Content

Support Center